Enteric-coated, pH-dependent peppermint oil capsules for the treatment of irritable bowel syndrome in children.
Quick navigation
Link to full study
http://www.ncbi.nlm.nih.gov/pubmed/11148527
Conclusion of this study
In a randomized, double-blind controlled trial, 42 children with irritable bowel syndrome (IBS) were given pH-dependent, enteric-coated peppermint oil capsules or placebo. After 2 weeks, 75% of those receiving peppermint oil had reduced severity of pain associated with IBS. Peppermint oil may be used as a therapeutic agent during the symptomatic phase of IBS.
Supplements analyzed in this study
Health conditions analyzed in this study
Functions related to this study
Body systems related to this study